NASDAQ:SMTI Sanara MedTech (SMTI) Stock Price, News & Analysis $32.68 +0.49 (+1.52%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$31.75▼$32.7350-Day Range$26.86▼$32.6952-Week Range$26.06▼$46.40Volume11,454 shsAverage Volume16,497 shsMarket Capitalization$282.03 millionP/E RatioN/ADividend YieldN/APrice Target$44.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Sanara MedTech alerts: Email Address Sanara MedTech MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside34.6% Upside$44.00 Price TargetShort InterestBearish4.87% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.50 out of 5 starsMedical Sector730th out of 936 stocksSurgical Appliances & Supplies Industry17th out of 18 stocks 3.5 Analyst's Opinion Consensus RatingSanara MedTech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSanara MedTech has only been the subject of 1 research reports in the past 90 days.Read more about Sanara MedTech's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.87% of the float of Sanara MedTech has been sold short.Short Interest Ratio / Days to CoverSanara MedTech has a short interest ratio ("days to cover") of 8.5.Change versus previous monthShort interest in Sanara MedTech has recently increased by 0.59%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSanara MedTech does not currently pay a dividend.Dividend GrowthSanara MedTech does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SMTI. Previous Next 2.0 News and Social Media Coverage News SentimentSanara MedTech has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Sanara MedTech this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Sanara MedTech to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sanara MedTech insiders have not sold or bought any company stock.Percentage Held by Insiders54.10% of the stock of Sanara MedTech is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.10% of the stock of Sanara MedTech is held by institutions.Read more about Sanara MedTech's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sanara MedTech is -55.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sanara MedTech is -55.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSanara MedTech has a P/B Ratio of 6.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Sanara MedTech's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Sanara MedTech Stock (NASDAQ:SMTI)Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.Read More SMTI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SMTI Stock News HeadlinesMay 15, 2024 | insidermonkey.comSanara MedTech Inc. (NASDAQ:SMTI) Q1 2024 Earnings Call TranscriptMay 15, 2024 | finance.yahoo.comSanara MedTech Inc (SMTI) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ...July 26, 2024 | Behind the Markets (Ad)J.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."May 14, 2024 | investorplace.comSMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024May 13, 2024 | finance.yahoo.comSanara MedTech Inc. Reports First Quarter 2024 Results: Revenue Surges, Losses WidenMay 13, 2024 | globenewswire.comSanara MedTech Inc. Announces First Quarter 2024 ResultsMay 12, 2024 | finance.yahoo.comInsiders own 30% of Sanara MedTech Inc. (NASDAQ:SMTI) shares but individual investors control 32% of the companyApril 29, 2024 | globenewswire.comSanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call DatesJuly 26, 2024 | Behind the Markets (Ad)J.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."April 18, 2024 | globenewswire.comSanara MedTech Inc. Announces $55 Million Debt FacilityApril 11, 2024 | investing.comSanara Medtech Inc (SMTI)April 5, 2024 | markets.businessinsider.comSanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-marketApril 5, 2024 | globenewswire.comSanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy OfficerMarch 29, 2024 | finance.yahoo.comSanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | seekingalpha.comSanara MedTech Inc. (SMTI) Q4 2023 Earnings Call TranscriptMarch 25, 2024 | investorplace.comSMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023March 25, 2024 | finance.yahoo.comSanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023March 25, 2024 | globenewswire.comSanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 ResultsSee More Headlines Receive SMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:SMTI CUSIPN/A CIK714256 Webwww.wndm.com Phone(817) 529-2300FaxN/AEmployees60Year FoundedN/APrice Target and Rating Average Stock Price Target$44.00 High Stock Price Target$44.00 Low Stock Price Target$44.00 Potential Upside/Downside+34.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,300,000.00 Net Margins-7.19% Pretax Margin-7.39% Return on Equity-11.33% Return on Assets-7.02% Debt Debt-to-Equity Ratio0.20 Current Ratio1.35 Quick Ratio1.02 Sales & Book Value Annual Sales$64.99 million Price / Sales4.34 Cash FlowN/A Price / Cash FlowN/A Book Value$5.22 per share Price / Book6.26Miscellaneous Outstanding Shares8,630,000Free Float3,959,000Market Cap$282.03 million OptionableNot Optionable Beta1.59 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Ronald T. Nixon (Age 68)Executive Chairman & CEO Comp: $100kMr. Michael D. McNeil (Age 59)CFO & Corporate Secretary Comp: $331.1kMr. Jacob A. WaldropChief Operating OfficerMr. Bill FitzgeraldChief Compliance OfficerMs. Tricia MattesonVice President of MarketingMr. Tyler PalmerChief Corporate Development & Strategy OfficerDr. Christopher A. Morrison FACHM (Age 54)FAPWCA, FCCWS, M.D., President of Telehealth Services Comp: $156kDr. Rebecca Erin Mcmahon (Age 39)President of Research & Development Mr. Seth YonPresident of CommercialMr. Callon NicholsVice President of Corporate OperationsMore ExecutivesKey CompetitorsAvanos MedicalNYSE:AVNSJin Medical InternationalNASDAQ:ZJYLInogenNASDAQ:INGNLakeland IndustriesNASDAQ:LAKENutribandNASDAQ:NTRBView All CompetitorsInstitutional OwnershipPrice T Rowe Associates Inc. MDBought 322 shares on 5/15/2024Ownership: 0.067%Vanguard Group Inc.Bought 4,348 shares on 5/10/2024Ownership: 1.675%Janney Montgomery Scott LLCSold 1,017 shares on 5/1/2024Ownership: 0.166%View All Institutional Transactions SMTI Stock Analysis - Frequently Asked Questions How have SMTI shares performed this year? Sanara MedTech's stock was trading at $41.10 on January 1st, 2024. Since then, SMTI shares have decreased by 20.5% and is now trading at $32.68. View the best growth stocks for 2024 here. How were Sanara MedTech's earnings last quarter? Sanara MedTech Inc. (NASDAQ:SMTI) announced its earnings results on Monday, May, 13th. The company reported ($0.21) EPS for the quarter. The firm earned $18.54 million during the quarter. Sanara MedTech had a negative trailing twelve-month return on equity of 11.33% and a negative net margin of 7.19%. How do I buy shares of Sanara MedTech? Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Sanara MedTech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL) and Abbott Laboratories (ABT). This page (NASDAQ:SMTI) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.